Seginus Cure Pharma, established in 2017, has been restructured and renamed as Seginus Pharma, now operating as a partnership firm from 2025 onwards. Our pharmaceutical development, marketing, and distribution activities will continue without any changes.
All existing contracts, partnerships, and product standards remain fully valid. Regulatory and GST updates have been completed.
For any queries or record updates, please contact our administration team.
– Management, Seginus Pharma